Topic
Semiconductor Research
Research across global markets indicates a robust environment for technology-related sectors, driven largely by Nasdaq outperformance and the ongoing integration of AI. The transition of biotechnology toward a scalable industry relies heavily on AI-driven drug discovery, a trend that underscores the increasing importance of high-performance computing infrastructure. Tactical regional themes, particularly in Asian technology, are highlighted as key opportunities for satellite portfolios seeking growth. Furthermore, the global tech economy’s strength is reflected in institutional hedging shifts and record equity highs, despite market caution regarding the exact pace of AI monetization. Recent technical moves, including a 25-year record outperformance in software relative to the S&P 500, suggest a period of high factor volatility and concentrated demand in tech-adjacent growth sectors. As markets navigate these geopolitical and technical shifts, analysts recommend enhancing portfolio resilience through exposure to resilient global markets like Japan and diversifying into alternative assets.
4222 reports available
All reports
Page 136 of 148
1Q26 Takeaways: Slight Core Beat with Stronger Top Line Across the Board
Goldman Sachs · May 11, 2026
Vista Energy New 2026-30 Outlook Unveiled
Goldman Sachs · May 11, 2026
Managing Allocations in Volatile Markets
Standard Chartered Global Private Bank · May 11, 2026
Metcash First Take
Goldman Sachs · May 11, 2026
Futures Global Equity CTA Market Update
Goldman Sachs & Co. LLC · May 11, 2026
Global Week Ahead: Separation Anxiety
Scotiabank · May 11, 2026
Global Shipyard Logbook May
Goldman Sachs · May 11, 2026
Investor Day: High Growth Portfolio Achieved Critical Mass
Goldman Sachs · May 11, 2026
Hannover Re Data Update Following 1Q26 Results
Goldman Sachs · May 11, 2026
Trust in AI
J.P. Morgan · May 11, 2026
Top Ten Questions Answered
UBS · May 11, 2026
How Income Investors Can Tackle Higher Inflation
UBS · May 11, 2026
Incyte Corp Management Meeting Frames Revenue-Replacement Strategy
Goldman Sachs · May 11, 2026
House View Daily Asia
UBS · May 11, 2026
Bath & Body Works Promotional Activity Update
Goldman Sachs · May 11, 2026
Chinese OEM Competition Monitor April 2026
Goldman Sachs · May 11, 2026
MENA Chemicals: Recapping 1Q26 Trends and Updating Numbers
Goldman Sachs · May 11, 2026
Dividend Screener
UBS · May 11, 2026
Philip Morris International: ZYN Ultra Rollout Following FDA Guidance
Goldman Sachs · May 11, 2026
Mosaic Q1 Results and Phosphate Production Curtailments
Goldman Sachs · May 11, 2026
Deutsche Bank Updating Estimates Post Q1 2026
Goldman Sachs · May 11, 2026
Samsung Biologics NDR Takeaway
Goldman Sachs · May 11, 2026
Chasing Momentum Into the Void
The Market Ear · May 11, 2026
Deep Dive Into Anduril's Lattice Software Post Leadership Meetings
Goldman Sachs · May 11, 2026